Shimadzu Corporation has announced plans to expand its operations in India with the establishment of a new manufacturing subsidiary, Shimadzu Manufacturing India Private Limited (SMI), in Bengaluru, Karnataka. The plant is expected to be completed and operational by the spring of 2027. Additionally, the company will integrate its existing sales subsidiaries in the country to form Shimadzu India Private Limited (SIP) by the summer of 2025.
The manufacturing facility will cover 40,000 square meters, with a 5,500-square-meter building, and will employ approximately 50 people in its first year. SMI will produce analytical and measuring instruments, including liquid chromatographs, gas chromatographs, UV-VIS spectrophotometers, liquid chromatograph mass spectrometers, and gas chromatograph mass spectrometers. Future production may include medical systems and industrial machinery.
Currently, Shimadzu supplies the Indian market from Japan and its facility in Malaysia. The new plant aims to strengthen the company’s supply chain and align with India’s domestic manufacturing policies.
The new sales subsidiary, SIP, will be a wholly owned subsidiary of Shimadzu (Asia Pacific) Pte. Ltd., the company’s regional headquarters in Singapore. It will handle sales and services for analytical and measuring instruments, medical systems, and industrial machinery in India. The integration of the existing sales subsidiaries, originally established in 2001 and 2005, aims to improve coordination between medical and analytical business segments.
Shimadzu projects sales in India to reach approximately 47 billion yen by fiscal year 2035, which is around 2.6 times the sales level of fiscal year 2023. The company expects these structural changes to enhance its presence in the Indian market.
According to the press release, the manufacturing subsidiary is scheduled to be established by the end of March 2025, while the sales subsidiary will be formed by mid-2025. Manabu Sakamoto has been named as the managing director of SIP.